Second to none

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials.

Original languageEnglish (US)
Pages (from-to)1537-1539
Number of pages3
JournalBlood
Volume120
Issue number8
DOIs
StatePublished - Aug 23 2012

    Fingerprint

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this